JODI GILMER: Open Payments
NPI 1144671769 · MILLEN, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$293 in 15 payments from 8 companies in 2025. Trend: 2023 $69 · 2024 $305 · 2025 $293
Food & beverage: $293
| Company | Payments | Amount |
|---|---|---|
| Philips North America LLC | 3 | $71 |
| Novo Nordisk Inc | 4 | $64 |
| Amgen Inc. | 3 | $52 |
| Exact Sciences Corporation | 1 | $25 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $23 |
| AstraZeneca Pharmaceuticals LP | 1 | $22 |
| Lilly USA, LLC | 1 | $22 |
| Athena Bioscience, LLC | 1 | $15 |
Products named: Ambulatory Monitoring & Diagnostics Undivided, REPATHA, Cologuard Collection Kit, CAPLYTA, AIRSUPRA, MOUNJARO, Rybelsus, Ozempic.
Industry payments across GA — which companies pay providers there.
